Berlin - Delayed Quote EUR

Exelixis Inc (EX9.BE)

19.79 -0.05 (-0.28%)
As of 8:01 AM GMT+2. Market Open.

Key Executives

Exelixis Inc

Description

Corporate Governance

Exelixis Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 30, 2024 at 10:59 AM UTC - August 5, 2024 at 12:00 PM UTC

Exelixis Inc Earnings Date

Recent Events

April 30, 2024 at 9:00 PM UTC

Q1 2024 Earnings Call

March 12, 2024 at 1:20 PM UTC

at Leerink Partners Global Biopharma Conference

March 5, 2024 at 3:30 PM UTC

at TD Cowen Health Care Conference

February 13, 2024 at 5:40 PM UTC

at Oppenheimer Healthcare Life Sciences Conference

February 8, 2024 at 2:00 PM UTC

at Guggenheim Healthcare Talks Biotechnology Conference

February 6, 2024 at 10:00 PM UTC

Q4 2023 Earnings Call

Related Tickers

NRXP NRx Pharmaceuticals, Inc.
3.5600
+0.56%
 
NOVO-B.CO Novo Nordisk A/S
936.20
+1.33%
 
NVO Novo Nordisk A/S
141.19
+0.91%
 
NVAX Novavax, Inc.
21.08
+18.69%